Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 9.36 is 342% above its 5-year average of 2.12, near the high end of its 5-year range (1.00–10.38).
As of the fiscal period ended Tuesday, June 30, 2026. 52.66% above its 12-month average of 6.13.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.36.
CURRENT RATIO
9.36
CURRENT RATIO AVG TTM
6.13
CURRENT RATIO AVG 3Y
1.91
CURRENT RATIO AVG 5Y
2.12
CURRENT RATIO AVG 10Y
3.45
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+52.66%
CURRENT VS 3Y AVG
+391.05%
CURRENT VS 5Y AVG
+342.12%
CURRENT VS 10Y AVG
+171.24%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.47
median of 680 covered companies
CURRENT VS SECTOR MEDIAN
+169.78%
vs the sector median at left
CytomX Therapeutics, Inc.
Market Cap
$568.81M
Current Ratio
9.36
TTM Avg
6.13
3Y Avg
1.91
5Y Avg
2.12
Market Cap
$574.60M
Current Ratio
7.19
TTM Avg
3.91
3Y Avg
2.77
5Y Avg
2.56
Market Cap
$561.45M
Current Ratio
3.46
TTM Avg
4.63
3Y Avg
6.00
5Y Avg
6.13
Market Cap
$556.18M
Current Ratio
5.42
TTM Avg
12.18
3Y Avg
12.18
5Y Avg
12.18
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | $568.81M | 9.36 | 6.13 | 1.91 | 2.12 |
| CorMedix Inc. (CRMD)vs › | $566.03M | 2.56 | 2.75 | 5.48 | 7.66 |
| Aquestive Therapeutics, Inc. (AQST)vs › | $574.60M | 7.19 | 3.91 | 2.77 | 2.56 |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $561.45M | 3.46 | 4.63 | 6.00 | 6.13 |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $556.18M | 5.42 | 12.18 | 12.18 | 12.18 |
| OrthoPediatrics Corp. (KIDS)vs › | $583.78M | 4.78 | 6.27 | 6.33 | 5.72 |
| Nuvectis Pharma, Inc. (NVCT)vs › | $551.43M | 1.68 | 2.23 | 2.63 | 2.59 |
| Fulgent Genetics, Inc. (FLGT)vs › | $591.58M | 6.34 | 5.67 | 6.35 | 5.88 |
| Immix Biopharma, Inc. (IMMX)vs › | $540.21M | 25.13 | 6.17 | 7.34 | 19.91 |
Current Ratio
9.36
Quick Ratio
9.36
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 9.36 |
| 2026-03-31 | 10.38 |
| 2025-12-31 | 3.09 |
| 2025-09-30 | 3.64 |
| 2025-06-30 | 4.20 |
| 2025-03-31 | 1.73 |
| 2024-12-31 | 1.25 |
| 2024-09-30 | 1.04 |
| 2024-06-30 | 1.00 |
| 2024-03-31 | 1.16 |
| 2023-12-31 | 1.17 |
| 2023-09-30 | 1.37 |
| 2023-06-30 | 1.33 |
| 2023-03-31 | 1.40 |
| 2022-12-31 | 1.55 |
| 2022-09-30 | 2.05 |
| 2022-06-30 | 2.34 |
| 2022-03-31 | 2.61 |
| 2021-12-31 | 3.98 |
| 2021-09-30 | 2.42 |
| 2021-06-30 | 2.90 |
| 2021-03-31 | 4.08 |
| 2020-12-31 | 4.76 |
| 2020-09-30 | 3.34 |
| 2020-06-30 | 3.71 |
| 2020-03-31 | 3.77 |
| 2019-12-31 | 3.54 |
| 2019-09-30 | 4.40 |
| 2019-06-30 | 4.66 |
| 2019-03-31 | 4.21 |
| 2018-12-31 | 4.55 |
| 2018-09-30 | 5.48 |
| 2018-06-30 | 4.41 |
| 2018-03-31 | 5.27 |
| 2017-12-31 | 6.36 |
| 2017-09-30 | 5.28 |
| 2017-06-30 | 5.62 |
| 2017-03-31 | 4.50 |
| 2016-12-31 | 5.26 |
| 2016-09-30 | 7.74 |
| 2016-06-30 | 8.98 |
| 2016-03-31 | 10.85 |
| 2015-12-31 | 12.06 |
| 2015-09-30 | 8.24 |
| 2015-06-30 | 11.63 |
| 2015-03-31 | 5.78 |
| 2014-12-31 | 5.99 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
